Etrolizumab-s fails to control E-Cadherin-dependent co-stimulation of highly activated cytotoxic T cells.
Wiendl M, Dedden M, Liu LJ, Schweda A, Paap EM, Ullrich KA, Hartmann L, Wieser L, Vitali F, Atreya I, Müller TM, Günther C, Atreya R, Neurath MF, Zundler S.
Wiendl M, et al. Among authors: wieser l.
Nat Commun. 2024 Feb 3;15(1):1043. doi: 10.1038/s41467-024-45352-6.
Nat Commun. 2024.
PMID: 38310086
Free PMC article.